Category Internal Medicine

Osteoporosis

Definition Osteoporosis is defined as a skeletal disorder that is characterized by compromised bone strength and that predisposes to an increased risk for fracture. The pertinent clinical outcomes of this disease include fractures, bone pain, loss of height, and physical…

Intimate Partner Violence

Definition Intimate partner violence is defined as any behavior that is within an intimate relationship or ex-relationship and that causes physical, psychological, or sexual harm. Such behaviors can include physical aggression, such as hitting, kicking, and beating; psychological violence, such…

Menopause

Definition Menopause is defined as the permanent cessation of menses and is the culmination of a process of reproductive aging that typically occurs in the fifth to sixth decades of life, with a median age of 52.5 years. Epidemiology Menopause…

Repirinast

General information Repirinast is an antiallergic prodrug which is de-esterified to an active metabolite that has a stabilizing action on mast cells resembling that of sodium cromoglicate [ ]. You’re Reading a Preview Become a Clinical Tree membership for Full…

Remifentanil

See also Opioid receptor agonists General information Remifentanil is a pure μ opioid (OP 3 , MOR) receptor agonist with a very short duration of action. It therefore has to be given by continuous intravenous infusion and is used as…

Remacemide

General information Remacemide hydrochloride is a low-affinity, non-competitive N-methyl- d -aspartate (NMDA) receptor blocker that has been used in epilepsy, Parkinson's disease, Huntington's chorea [ ], and neuroprotection after stroke [ ]. Its pharmacology, clinical pharmacology, uses, and adverse reactions…

Reboxetine

General information Reboxetine is a selective noradrenaline re-uptake inhibitor with low affinity for α-adrenoceptors and muscarinic receptors [ ]. In controlled trials the following adverse events occurred significantly more often with reboxetine than with placebo: dry mouth (27%), constipation (17%),…

Razaxaban

General information Razaxaban, a selective oral direct factor Xa inhibitor [ , ], was discontinued by the manufacturer after the three higher doses in a dose-ranging study in venous thromboembolism caused an increased risk of bleeding. You’re Reading a Preview…